Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
2,556,332
-
Total 13F shares
-
3,293,470
-
Share change
-
+213,458
-
Total reported value
-
$6,618,000
-
Price per share
-
$2.00
-
Number of holders
-
20
-
Value change
-
+$430,254
-
Number of buys
-
13
-
Number of sells
-
6
Institutional Holders of Aptose Biosciences Inc. - Common Shares as of Q1 2019
As of 31 Mar 2019 Aptose Biosciences Inc. - Common Shares had 20 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 3,293,470 shares of stock of the company.
Largest 10 holders included DRW Securities, LLC, MORGAN STANLEY, Virtu Financial LLC, Patriot Financial Group Insurance Agency, LLC, Nantahala Capital Management, LLC, CITADEL ADVISORS LLC, US BANCORP \DE\, Squarepoint Ops LLC, TWO SIGMA ADVISERS, LP, and Noven Financial Group, Inc..
This table shows 21 institutional shareholders of the security as of 31 Mar 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.